Peter R Gibson

Summary

Affiliation: Monash University
Country: Australia

Publications

  1. ncbi Effects of methylnaltrexone in patients with narcotic bowel syndrome: a pilot observational study
    P R Gibson
    Eastern Health Clinical School, Monash University, Melbourne, Victoria, Australia
    Intern Med J 42:907-12. 2012
  2. ncbi Food choice as a key management strategy for functional gastrointestinal symptoms
    Peter R Gibson
    Department of Gastroenterology, Alfred Hospital, Monash University, Melbourne, Victoria, Australia
    Am J Gastroenterol 107:657-66; quiz 667. 2012
  3. ncbi Food intolerance in functional bowel disorders
    Peter R Gibson
    Eastern Health Clinical School, Monash University and Eastern Health, Box Hill, Victoria, Australia
    J Gastroenterol Hepatol 26:128-31. 2011
  4. ncbi Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome
    Derrick K Ong
    Department of Medicine, Eastern Health Clinical School, Monash University, Victoria, Australia
    J Gastroenterol Hepatol 25:1366-73. 2010
  5. ncbi Measurement of short-chain carbohydrates in common Australian vegetables and fruits by high-performance liquid chromatography (HPLC)
    Jane G Muir
    Department of Medicine, Monash University, Box Hill Hospital, Clive Ward Centre, Victoria, Australia
    J Agric Food Chem 57:554-65. 2009
  6. ncbi Gluten causes gastrointestinal symptoms in subjects without celiac disease: a double-blind randomized placebo-controlled trial
    Jessica R Biesiekierski
    Monash University Department of Medicine and Gastroenterology, Box Hill Hospital, Box Hill, Victoria, Australia
    Am J Gastroenterol 106:508-14; quiz 515. 2011
  7. ncbi Benefits of breath hydrogen testing after lactulose administration in analysing carbohydrate malabsorption
    John P Bate
    Departments of Medicine and Gastroenterology, Monash University, Box Hill Hospital, Box Hill, Victoria, Australia
    Eur J Gastroenterol Hepatol 22:318-26. 2010
  8. ncbi Clinical usefulness of therapeutic drug monitoring of thiopurines in patients with inadequately controlled inflammatory bowel disease
    Melissa L Haines
    Department of Medicine, Eastern Health, Monash University, Victoria, Australia
    Inflamm Bowel Dis 17:1301-7. 2011
  9. ncbi Dietary triggers of abdominal symptoms in patients with irritable bowel syndrome: randomized placebo-controlled evidence
    Susan J Shepherd
    Department of Gastroenterology and Monash University Department of Medicine, Box Hill Hospital, Victoria, Australia
    Clin Gastroenterol Hepatol 6:765-71. 2008
  10. ncbi Evidence-based dietary management of functional gastrointestinal symptoms: The FODMAP approach
    Peter R Gibson
    Monash University Department of Medicine, Box Hill Hospital, Box Hill, Victoria, Australia
    J Gastroenterol Hepatol 25:252-8. 2010

Collaborators

Detail Information

Publications28

  1. ncbi Effects of methylnaltrexone in patients with narcotic bowel syndrome: a pilot observational study
    P R Gibson
    Eastern Health Clinical School, Monash University, Melbourne, Victoria, Australia
    Intern Med J 42:907-12. 2012
    ..Narcotic bowel syndrome (NBS) describes disabling chronic severe abdominal pain that worsens despite continuing or escalating doses of opiates. Therapy is very limited...
  2. ncbi Food choice as a key management strategy for functional gastrointestinal symptoms
    Peter R Gibson
    Department of Gastroenterology, Alfred Hospital, Monash University, Melbourne, Victoria, Australia
    Am J Gastroenterol 107:657-66; quiz 667. 2012
    ..Food choice via the low FODMAP and potentially other dietary strategies is now a realistic and efficacious therapeutic approach for functional gut symptoms...
  3. ncbi Food intolerance in functional bowel disorders
    Peter R Gibson
    Eastern Health Clinical School, Monash University and Eastern Health, Box Hill, Victoria, Australia
    J Gastroenterol Hepatol 26:128-31. 2011
    ..This reviews aims to discuss strategies commonly applied...
  4. ncbi Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome
    Derrick K Ong
    Department of Medicine, Eastern Health Clinical School, Monash University, Victoria, Australia
    J Gastroenterol Hepatol 25:1366-73. 2010
    ..In the present study, we aimed to compare the patterns of breath hydrogen and methane and symptoms produced in response to diets that differed only in FODMAP content...
  5. ncbi Measurement of short-chain carbohydrates in common Australian vegetables and fruits by high-performance liquid chromatography (HPLC)
    Jane G Muir
    Department of Medicine, Monash University, Box Hill Hospital, Clive Ward Centre, Victoria, Australia
    J Agric Food Chem 57:554-65. 2009
    ..53-5.99 g/100 g of fw), mannitol was found in 2 fruits, and nystose or kestose was measured in 8 fruits. Understanding the importance of dietary FODMAPs will be greatly assisted by comprehensive food composition data...
  6. ncbi Gluten causes gastrointestinal symptoms in subjects without celiac disease: a double-blind randomized placebo-controlled trial
    Jessica R Biesiekierski
    Monash University Department of Medicine and Gastroenterology, Box Hill Hospital, Box Hill, Victoria, Australia
    Am J Gastroenterol 106:508-14; quiz 515. 2011
    ..The aims of this study were to determine whether gluten ingestion can induce symptoms in non-celiac individuals and to examine the mechanism...
  7. ncbi Benefits of breath hydrogen testing after lactulose administration in analysing carbohydrate malabsorption
    John P Bate
    Departments of Medicine and Gastroenterology, Monash University, Box Hill Hospital, Box Hill, Victoria, Australia
    Eur J Gastroenterol Hepatol 22:318-26. 2010
    ..We examined the contribution of breath testing after lactulose administration to the conduct and interpretation of breath hydrogen responses after fructose and lactose administration...
  8. ncbi Clinical usefulness of therapeutic drug monitoring of thiopurines in patients with inadequately controlled inflammatory bowel disease
    Melissa L Haines
    Department of Medicine, Eastern Health, Monash University, Victoria, Australia
    Inflamm Bowel Dis 17:1301-7. 2011
    ..This study aimed to examine retrospectively the utility of measuring metabolite concentrations in patients with inflammatory bowel disease (IBD) who had continuing symptoms despite stable thiopurine treatment...
  9. ncbi Dietary triggers of abdominal symptoms in patients with irritable bowel syndrome: randomized placebo-controlled evidence
    Susan J Shepherd
    Department of Gastroenterology and Monash University Department of Medicine, Box Hill Hospital, Victoria, Australia
    Clin Gastroenterol Hepatol 6:765-71. 2008
    ....
  10. ncbi Evidence-based dietary management of functional gastrointestinal symptoms: The FODMAP approach
    Peter R Gibson
    Monash University Department of Medicine, Box Hill Hospital, Box Hill, Victoria, Australia
    J Gastroenterol Hepatol 25:252-8. 2010
    ..The link between food intake and symptom induction is recognized. This review aims to describe the evidence base for restricting rapidly fermentable, short-chain carbohydrates (FODMAPs) in controlling such symptoms...
  11. ncbi Probiotic effects on intestinal fermentation patterns in patients with irritable bowel syndrome
    Jacqueline S Barrett
    Department of Medicine, and Department of Gastroenterology, Monash University, Box Hill Hospital, Box Hill, Victoria 3128, Australia
    World J Gastroenterol 14:5020-4. 2008
    ....
  12. ncbi Pilot study on the effect of reducing dietary FODMAP intake on bowel function in patients without a colon
    Catherine Croagh
    Department of Gastroenterology and Monash University Department of Medicine, Box Hill Hospital, Victoria, Australia
    Inflamm Bowel Dis 13:1522-8. 2007
    ..The aim was to perform a proof-of-concept evaluation of this hypothesis...
  13. ncbi Reduction of dietary poorly absorbed short-chain carbohydrates (FODMAPs) improves abdominal symptoms in patients with inflammatory bowel disease-a pilot study
    Richard B Gearry
    Monash University Department of Medicine and Department of Gastroenterology, Box Hill Hospital, Box Hill, Victoria, Australia
    J Crohns Colitis 3:8-14. 2009
    ....
  14. ncbi Strategies to manage gastrointestinal symptoms complicating enteral feeding
    Jacqueline S Barrett
    Monash University, Department of Medicine, and Department of Gastroenterology, Box Hill Hospital, Box Hill Victoria, Australia
    JPEN J Parenter Enteral Nutr 33:21-6. 2009
    ..It has compelling theoretical support, but requires further investigation. A methodical clinical approach to gastrointestinal complications of enteral feeding is warranted and an algorithm for management is proposed...
  15. ncbi Overview of inflammatory bowel disease in Australia in the last 50 years
    Peter R Gibson
    Monash University Department of Medicine, Box Hill Hospital, Box Hill, Victoria, Australia
    J Gastroenterol Hepatol 24:S63-8. 2009
    ..Underpinning the success has been clinical excellence and adaptation of clinicians to the changing landscape of disease severity and therapeutic options. The future is indeed bright if such trends continue...
  16. ncbi Development and validation of a comprehensive semi-quantitative food frequency questionnaire that includes FODMAP intake and glycemic index
    Jacqueline S Barrett
    Monash University, Eastern Health Clinical School, Victoria, Australia
    J Am Diet Assoc 110:1469-76. 2010
    ..Such hypotheses cannot be tested without the ability to quantify FODMAP ingestion with a validated dietary assessment tool...
  17. ncbi The concept of small intestinal bacterial overgrowth in relation to functional gastrointestinal disorders
    Peter R Gibson
    Department of Medicine, Monash University, Box Hill Hospital, Victoria, Australia
    Nutrition 26:1038-43. 2010
    ..Controversy will continue until concepts are broadened, consensus in definition is reached, and evaluation of efficacy of candidate therapies is more rigorous...
  18. ncbi Fructose and lactose testing
    Jacqueline S Barrett
    Gastroenterology Department, Alfred Hospital and Central Clinical School, Monash University, Melbourne, Victoria
    Aust Fam Physician 41:293-6. 2012
    ..While part of the GP's role is excluding other pathology, helping patients to manage their symptoms is also important...
  19. ncbi Fructan and free fructose content of common Australian vegetables and fruit
    Jane G Muir
    Monash University, Department of Medicine, Box Hill Hospital, Victoria 3128, Australia
    J Agric Food Chem 55:6619-27. 2007
    ..Research in this area will be facilitated through the availability of more comprehensive food composition data...
  20. ncbi Endoscopic balloon dilatation of intestinal strictures in Crohn's disease: safe alternative to surgery
    Yousef Ajlouni
    IBD Clinic, Box Hill Hospital, Melbourne, Victoria, Australia
    J Gastroenterol Hepatol 22:486-90. 2007
    ..This study aimed to determine the outcomes of EBD by a single endoscopist using a defined technique...
  21. ncbi Cytomegalovirus disease, haemophagocytic syndrome, immunosuppression in patients with IBD: 'a cocktail best avoided, not stirred'
    Daniel R van Langenberg
    Monash University Department of Gastroenterology and Hepatology, Medicine, Box Hill Hospital, Victoria, Australia
    J Crohns Colitis 5:469-72. 2011
    ..CMV-related haemophagocytic syndrome and organ dysfunction, in the context of immunomodulator therapy in IBD are rare but life-threatening, and thus requires further investigation and discussion...
  22. ncbi Fructose malabsorption and symptoms of irritable bowel syndrome: guidelines for effective dietary management
    Susan J Shepherd
    Department of Gastroenterology and Monash University, Victoria, Australia
    J Am Diet Assoc 106:1631-9. 2006
    ..01), as was improvement in individual symptoms (P<0.01 for all symptoms). This comprehensive fructose malabsorption dietary therapy achieves a high level of sustained adherence and good symptomatic response...
  23. ncbi Infections and IBD
    Peter M Irving
    Department of Gastroenterology, Box Hill Hospital, Box Hill, Victoria, Australia
    Nat Clin Pract Gastroenterol Hepatol 5:18-27. 2008
    ..Meanwhile, intriguing advances in the use of parasitic agents as a treatment for ulcerative colitis and Crohn's disease have introduced a new angle to the interplay between infections and IBD...
  24. ncbi A single center experience of methotrexate in the treatment of Crohn's disease and ulcerative colitis: a case for subcutaneous administration
    Debbie M Nathan
    Department of Gastroenterology and Monash University Department of Medicine, Box Hill Hospital, Victoria, Australia
    J Gastroenterol Hepatol 23:954-8. 2008
    ..This study aimed to evaluate the response to and tolerance of MTX where subcutaneous administration was the preferred option...
  25. ncbi Relationship between disease severity, quality of life and health-care resource use in a cross-section of Australian patients with Crohn's disease
    Peter R Gibson
    Monash University Department of Medicine and Department of Gastroenterology, Box Hill Hospital, Box Hill, Victoria, Australia
    J Gastroenterol Hepatol 22:1306-12. 2007
    ..This study aimed to correlate disease severity with health-related quality of life and with health-care resource use, to allow evaluation of the cost effectiveness of these treatments...
  26. ncbi Alternative investigations for irritable bowel syndrome
    Hamish Philpott
    Eastern Health Clinical School, Monash University, Box Hill, Melbourne, Victoria, Australia
    J Gastroenterol Hepatol 28:73-7. 2013
    ..The aim of the present study was to examine the alternative investigations that are advocated for the assessment of gastrointestinal disease and that are available through mainstream laboratories in Australia...
  27. ncbi Fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAPs) and nonallergic food intolerance: FODMAPs or food chemicals?
    Jacqueline S Barrett
    Eastern Health Clinical School, Monash University, Level 2, 5 Arnold Street, Box Hill, Victoria 3128, Australia
    Therap Adv Gastroenterol 5:261-8. 2012
    ....
  28. ncbi 5-Aminosalicylic acid (mesalazine) use in Crohn's disease: a survey of the opinions and practice of Australian gastroenterologists
    Richard B Gearry
    Monash University Department of Medicine and Department of Gastroenterology, Box Hill Hospital, Box Hill, Victoria, Australia
    Inflamm Bowel Dis 13:1009-15. 2007
    ....